Progress in osteoporosis and fracture prevention: focus on postmenopausal women
Open Access
- 1 January 2009
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 11 (5) , 251
Abstract
In the past decade, we have witnessed a revolution in osteoporosis diagnosis and therapeutics. This includes enhanced understanding of basic bone biology, recognizing the severe consequences of fractures in terms of morbidity and short-term re-fracture and mortality risk and case finding based on clinical risks, bone mineral density, new imaging approaches, and contributors to secondary osteoporosis. Medical interventions that reduce fracture risk include sufficient calcium and vitamin D together with a wide spectrum of drug therapies (with antiresorptive, anabolic, or mixed effects). Emerging therapeutic options that target molecules of bone metabolism indicate that the next decade should offer even greater promise for further improving our diagnostic and treatment approaches.Keywords
This publication has 175 references indexed in Scilit:
- Distribution and Correlates of Serum 25-Hydroxyvitamin D Levels in a Sample of Patients with Hip FractureThe American Journal of Geriatric Pharmacotherapy, 2007
- Fracture prevention with vitamin D supplementation: considering the inconsistent resultsBMC Musculoskeletal Disorders, 2007
- Clinical relevance of vertebral fracturesAnnals of the Rheumatic Diseases, 2007
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical TrialsMayo Clinic Proceedings, 2002
- Ibandronate: A Comparison of Oral Daily Dosing Versus Intermittent Dosing in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2001
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Parathyroid hormone in the treatment of involutional osteoporosis: Back to the futureOsteoporosis International, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980